<DOC>
	<DOCNO>NCT00294398</DOCNO>
	<brief_summary>Specific Aim : To determine whether prescription Inhaled Corticosteroids ( ICS ) add standard Emergency Department ( ED ) discharge therapy young child persistent asthma symptom increase ICS use improve symptom quality life month follow ED visit . Hypotheses : In cohort pediatric patient persistent asthma discharge ED acute asthma exacerbation , prescription ICS : 1 . Improve usage ICS measure refill prescription within first 2 month ED visit 2 . Improve symptom severity two week ED visit measure day cough , wheeze , missed school , daycare work 3 . Improve patient caregiver asthma-related quality life 2 month follow ED visit measure asthma Health Related Quality Life ( HRQL ) 4 . Improve asthma control 2 month measure validated asthma instrument</brief_summary>
	<brief_title>Inhaled Corticosteroids After Pediatric Emergency Visit Asthma</brief_title>
	<detailed_description>Abstract . Background : Asthma prevalence , emergency visit , hospitalization increase substantially , especially among young child urban population . Although inhaled corticosteroid ( ICS ) mainstay treatment persistent asthma , study demonstrate low rate ICS usage primary care provider follow-up within month Emergency Department ( ED ) visit . Furthermore , ICS usage adherence National Asthma Education Prevention Program ( NAEPP ) recommendation low even child follow-up primary care physician ( PCP ) . In addition , study demonstrate frequent symptom , activity restriction , missed school work week follow ED visit . Prescribing ICS ED discharge occur uncommonly United States base survey review current practice . Adult study inconclusive role ICS pediatric emergency visit asthma study . This study assess short-term outcome prescribe ICS young child persistent asthma symptom emergency visit asthma . Objective : To determine whether prescription ICS add standard asthma ED discharge therapy young child persistent asthma increase adherence NAEPP guideline ICS usage 2 month follow improve short-term symptom quality life patient caregiver . Methods : Randomized control trial child 1- 8yo age persistent asthma discharge emergency visit asthma . Subjects randomize receive standard therapy oral corticosteroid , albuterol , education versus standard care plus prescription budesonide daily . A questionnaire administer baseline , follow-up telephone interview conduct 2 week 2 month . Pharmacy verification refill second prescription ICS primary outcome . Asthma symptom quality life assess secondary outcome .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Emergencies</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>1 . Age 12 month 18 year 2 . History asthma define 2 prior physician visit bronchodilator prescribe 3 . Persistent symptom identify asthma control tool base NAEPP Guidelines develop validated multidisciplinary team clinician CHOP Allergy , Pulmonary Medicine , General Pediatrics Emergency Medicine . 4 . Treated ED acute asthma plan discharge ED oral prednisone 5 . Have Primary Care Physician ( PCP ) 1 . Current hospitalization admission extend day emergency care unit 2 . History pediatric intensive care admission asthma 3 . Current prescription controller medication inhale corticosteroid ( ICS ) , leukotriene receptor antagonist , cromolyn 4 . Contraindications use routine asthma medication include betaagonists systemic steroid 5 . Comorbid disease : Chronic lung disease , example cystic fibrosis ; Congenital heart disease require surgery and/or medication ; Sickle cell disease ; Immunodeficiency syndromes 6 . Previous enrollment study</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Asthma , Controller Medications</keyword>
</DOC>